logo

For the Inventor, By the Inventor

Hanover, NH, United States of America

Glenn C Micalizio

This inventor holds 8 USPTO granted patents and 8 published patent applications. Top assignee: Dartmouth College. Active years: 2022-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Glenn C Micalizio. Retrieved from https://idiyas.com/inventor/glenn-c-micalizio

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 8 

% Patents Active = 100.0

Average Co-Inventor Count = 1.0

ph-index = 3

Forward Citations = 12(Granted Patents)


Location History:

  • Hanover, NH (US) (2022)
  • Norwich, VT (US) (2022 - 2024)

Company Filing History:

goldMedal8 out of 708 
 
Dartmouth College
 patents

Years Active: 2022-2026

Loading Chart...
8 patents (USPTO):Explore Patents
1. 12760060 - Androgen receptor modulators (2026-10-13),
2. 12760059 - Glucocorticoid receptor modulators (2026-10-13),
3. 12753202 - Androgen receptor modulators (2026-10-06),
4. 12391723 - Steroids and methods of manufacture (2025-08-19),
5. 12065465 - Methods for assembly of tetracyclic compounds by stereoselective C9-C10 bond formation (2024-08-20),
6. 11787835 - C19 scaffolds and steroids and methods of use and manufacture thereof (2023-10-17),
7. 11512107 - Methods for assembly of tetracyclic compounds by stereoselective C9-C10 bond formation (2022-11-29),
8. 11459353 - Steroids and methods of manufacture (2022-10-04),

Title: Glenn C Micalizio: Innovator in Steroidal Compounds

Introduction

Glenn C Micalizio is a prominent inventor based in Hanover, NH (US). He has made significant contributions to the field of chemistry, particularly in the development of steroidal compounds. With a total of 8 patents to his name, Micalizio's work has implications for both human and animal therapeutics.

Latest Patents

Micalizio's latest patents focus on innovative methods for producing enantiodefined polycyclic compounds, especially tetracyclic compounds. One of his notable patents describes methods for synthesizing biologically active enantiodefined steroidal compositions, which include both natural and unnatural absolute stereochemistry. An exemplary method involves forming a hydrindane intermediate through the coupling of a suitably functionalized enyne with a suitably functionalized alkyne, followed by an intramolecular ring-closing reaction to create the tetracyclic compound. Additionally, he has developed methods for assembling tetracyclic compounds through stereoselective C9-C10 bond formation, which can be used to treat diseases such as brain tumors, particularly gliomas.

Career Highlights

Micalizio is affiliated with Dartmouth College, where he continues to advance research in the field of chemistry. His work has garnered attention for its potential applications in therapeutic settings, showcasing his commitment to innovation and scientific advancement.

Conclusion

Glenn C Micalizio stands out as a key figure in the development of steroidal compounds, with a focus on innovative synthetic methods. His contributions to the field are paving the way for new therapeutic options in medicine.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…